research product . Other ORP type . 2021

Serological reconstruction of COVID-19 epidemics through analysis of antibody kinetics to SARS-CoV-2 proteins

Pelleau, Stéphane; Woudenberg, Tom; Rosado, Jason; Donnadieu, Françoise; Garcia, Laura; Obadia, Thomas; Gardais, Soazic; Elgharbawy, Yasmine; Velay, Aurelie; Gonzalez, Maria; ...
Open Access English
  • Published: 08 Mar 2021
  • Publisher: HAL CCSD
  • Country: France
Abstract
Pre-print article
Subjects
free text keywords: [SDV]Life Sciences [q-bio]
Related Organizations
Funded by
EC| SynarchiC
Project
SynarchiC
Investigating the functional architecture of microbial genomes with synthetic approaches
  • Funder: European Commission (EC)
  • Project Code: 771813
  • Funding stream: H2020 | ERC | ERC-COG
,
WT| Wellcome – Health Research Board Irish Clinical Academic Training Programme
Project
  • Funder: Wellcome Trust (WT)
  • Project Code: 203930
  • Funding stream: Education
,
EC| MultiSeroSurv
Project
MultiSeroSurv
Algorithms and multiplex assays for integrated serological surveillance of malaria and neglected tropical diseases
  • Funder: European Commission (EC)
  • Project Code: 852373
  • Funding stream: H2020 | ERC | ERC-STG
Communities
COVID-19
18 references, page 1 of 2

1. Salje H, Tran Kiem C, Lefrancq N, Courtejoie N, Bosetti P, et al. Estimating the burden of SARS-CoV-2 in France. Science. 2020; 369(6500): 208-211

2. Priesemann V, Balling R, Brinkmann MM, Ciesek S, Czypionka T, et al. An action plan for pan-European defence against new SARS-CoV-2 variants. Lancet. 2021; 397(10273): 469-470

3. Le Vu S, Jones G, Anna F, Rose T, Richard JP, et al. Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance. medRxiv. 2020; https://doi.org/10.1101/2020.10.20.20213116

4. Ward H, Cooke G, Atchison C, Whitaker M, Elliott, et al. Declining prevalence of antibody positivity to SARS-CoV2: a community study of 365,000 adults. medRxiv. 2020; https://doi.org/10.1101/2020.10.26.20219725

5. Kagucia EW, Gitonga JN, Kalu C, Ochomo E, Ochieng B, et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies among truck drivers and assistants in Kenya. medRxiv. 2020; https://doi.org/10.1101/2021.02.12.21251294

6. Dan JM, Mateus J, Kato Y, Hastie KM, Yu ED, et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science. 2021; 371(587)

7. To KK, Tsang OT, Leung WS, Tam AR, Wu TC, Lung DC, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020; S1473-3099(20)30196-1.

8. Iyer AS, Jones FK, Nodoushania A, Kelly M, Beckera M, et al. Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients. Science Immunol. 2020; 10.1126/sciimmunol.abe0367

9. Isho B, Abe KT, Zuo M, Jamal AJ, Rathod B, et al. Persistence of serum and saliva antibody responses to SARS-CoV2 spike antigens in COVID-19 patients. Science Immunol. 2020; 10.1126/sciimmunol.abe5511

10. Röltgen K, Powell AE, Wirz OF, Stevens BA, Hogan CA, et al. Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome. Science Immunol. 2020; 10.1126/sciimmunol.abe0240

11. Seow J, Graham C, Merrick B, Acors S, Pickering S, et al. Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans. Nat Microbio. 2020; 5: 1598- 1607

12. Tang F, Quan Y, Xin ZT, Wrammert J, Ma MJ, Lv H, et al. Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study. J Immunol. 2011; 186 (12) 7264- 7268

13. Callow KA, Parry HF, Sergeant M, Tyrrell DA. The time course of the immune response to experimental coronavirus infection of man. Epidemiol Infect. 1990; 105(2):435-46.

14. Choe PG, Perera RAPM, Park WB, Song KH, Bang JH, Kim ES, et al. MERS-CoV antibody responses 1 year after symptom onset, South Korea, 2015. Emerg Infect Dis. 2017; 23(7):1079-1084. [OpenAIRE]

15. Slifka MK, Antia R, Whitmire JK, Ahmed R. Humoral immunity due to long-lived plasma cells. Immunity. 1998; 8: 363-72

18 references, page 1 of 2
Abstract
Pre-print article
Subjects
free text keywords: [SDV]Life Sciences [q-bio]
Related Organizations
Funded by
EC| SynarchiC
Project
SynarchiC
Investigating the functional architecture of microbial genomes with synthetic approaches
  • Funder: European Commission (EC)
  • Project Code: 771813
  • Funding stream: H2020 | ERC | ERC-COG
,
WT| Wellcome – Health Research Board Irish Clinical Academic Training Programme
Project
  • Funder: Wellcome Trust (WT)
  • Project Code: 203930
  • Funding stream: Education
,
EC| MultiSeroSurv
Project
MultiSeroSurv
Algorithms and multiplex assays for integrated serological surveillance of malaria and neglected tropical diseases
  • Funder: European Commission (EC)
  • Project Code: 852373
  • Funding stream: H2020 | ERC | ERC-STG
Communities
COVID-19
18 references, page 1 of 2

1. Salje H, Tran Kiem C, Lefrancq N, Courtejoie N, Bosetti P, et al. Estimating the burden of SARS-CoV-2 in France. Science. 2020; 369(6500): 208-211

2. Priesemann V, Balling R, Brinkmann MM, Ciesek S, Czypionka T, et al. An action plan for pan-European defence against new SARS-CoV-2 variants. Lancet. 2021; 397(10273): 469-470

3. Le Vu S, Jones G, Anna F, Rose T, Richard JP, et al. Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance. medRxiv. 2020; https://doi.org/10.1101/2020.10.20.20213116

4. Ward H, Cooke G, Atchison C, Whitaker M, Elliott, et al. Declining prevalence of antibody positivity to SARS-CoV2: a community study of 365,000 adults. medRxiv. 2020; https://doi.org/10.1101/2020.10.26.20219725

5. Kagucia EW, Gitonga JN, Kalu C, Ochomo E, Ochieng B, et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies among truck drivers and assistants in Kenya. medRxiv. 2020; https://doi.org/10.1101/2021.02.12.21251294

6. Dan JM, Mateus J, Kato Y, Hastie KM, Yu ED, et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science. 2021; 371(587)

7. To KK, Tsang OT, Leung WS, Tam AR, Wu TC, Lung DC, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020; S1473-3099(20)30196-1.

8. Iyer AS, Jones FK, Nodoushania A, Kelly M, Beckera M, et al. Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients. Science Immunol. 2020; 10.1126/sciimmunol.abe0367

9. Isho B, Abe KT, Zuo M, Jamal AJ, Rathod B, et al. Persistence of serum and saliva antibody responses to SARS-CoV2 spike antigens in COVID-19 patients. Science Immunol. 2020; 10.1126/sciimmunol.abe5511

10. Röltgen K, Powell AE, Wirz OF, Stevens BA, Hogan CA, et al. Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome. Science Immunol. 2020; 10.1126/sciimmunol.abe0240

11. Seow J, Graham C, Merrick B, Acors S, Pickering S, et al. Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans. Nat Microbio. 2020; 5: 1598- 1607

12. Tang F, Quan Y, Xin ZT, Wrammert J, Ma MJ, Lv H, et al. Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study. J Immunol. 2011; 186 (12) 7264- 7268

13. Callow KA, Parry HF, Sergeant M, Tyrrell DA. The time course of the immune response to experimental coronavirus infection of man. Epidemiol Infect. 1990; 105(2):435-46.

14. Choe PG, Perera RAPM, Park WB, Song KH, Bang JH, Kim ES, et al. MERS-CoV antibody responses 1 year after symptom onset, South Korea, 2015. Emerg Infect Dis. 2017; 23(7):1079-1084. [OpenAIRE]

15. Slifka MK, Antia R, Whitmire JK, Ahmed R. Humoral immunity due to long-lived plasma cells. Immunity. 1998; 8: 363-72

18 references, page 1 of 2
Any information missing or wrong?Report an Issue